Stock Comparison

HLN vs UTHR

Haleon plc and United Therapeutics Corporation side by side — valuation, profitability, growth and risk.

Valuation

Market Cap
$43.55B
$21.87B
P/E (TTM)
20.2
18.3
Forward P/E
18.0
18.6
Price/Sales
3.9
6.9
Price/Book
2.0
3.4
EV/EBITDA
14.0
11.1
Dividend Yield
1.93%

Profitability

Net Margin
14.43%
41.56%
Operating Margin
21.32%
44.49%
Return on Equity
10.10%
19.30%
Return on Assets
5.08%
11.60%

Growth (YoY)

Revenue Growth
2.20%
-1.90%
Earnings Growth
-4.50%
13.40%

Price & Risk

Beta
0.2
0.6
52-Week High
$11.12
$596.76
52-Week Low
$8.61
$304.76
Analyst Target
$11.99
$658.08

Compare HLN and UTHR your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.